Two small clinical trials tested the safety of injecting stem cells into the brains of Parkinson's patients and found no ...

Scientists at the University of California, Riverside, have discovered how adult stem cells retain their regenerative power.

Parkinson’s is a progressive neurological condition driven by the loss of dopamine-producing neurons, which causes tremors, ...

Adult stem cells can be altered to have the ... There’s no FDA-approved stem cell therapy for Parkinson’s, but clinical ...

Two independent clinical trials demonstrate the safety of stem cell therapies for Parkinson's disease. The papers, published ...

Techniques that cause multipotent adult mesenchymal stem cells (MSCs) to differentiate ... activities in the OA joint. Targeted gene therapy might further enhance these activities of MSCs.

In partnership with the National Institute of Allergy and Infectious Diseases, we committed nearly $4 million over five years to co-fund a major study of mesenchymal (adult) stromal cells as a new ...

Neuroscientific Biopharmaceuticals Ltd. ( ($AU:NSB) ) has issued an announcement. NeuroScientific Biopharmaceuticals Ltd announced its acquisition ...

A crucial requirement for MSC-based OA therapy is the delivery of the cells to the defect site. Direct intra-articular injection might be possible in early stages of the disease when the defect is ...